ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,874.85
      1.70%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aclaris Therapeutics Inc (ACRS)

      7. Aclaris Therapeutics Inc (ACRS) News

      ACRS

      Aclaris Therapeutics (ACRS)

      Aclaris Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ACRS
      DateTimeSourceHeadlineSymbolCompany
      06/22/20234:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      06/20/20234:32PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ACRSAclaris Therapeutics Inc
      06/20/20234:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      06/13/20237:01AMGlobeNewswire Inc.Aclaris Therapeutics Completes Enrollment in Phase 2b Study of Oral Zunsemetinib (ATI-450) for Moderate to Severe Rheumatoid Arthritis (ATI-450-RA-202)NASDAQ:ACRSAclaris Therapeutics Inc
      06/12/20234:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      06/05/20235:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      06/05/20235:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      06/05/20235:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      06/05/20235:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      06/05/20234:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      06/02/20237:00AMGlobeNewswire Inc.Aclaris Therapeutics to Participate in Two June Healthcare Investor ConferencesNASDAQ:ACRSAclaris Therapeutics Inc
      06/01/20234:19PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      05/08/20234:06PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ACRSAclaris Therapeutics Inc
      05/08/20237:31AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRSAclaris Therapeutics Inc
      05/08/20237:00AMGlobeNewswire Inc.Aclaris Therapeutics Reports First Quarter 2023 Financial Results and Provides a Corporate UpdateNASDAQ:ACRSAclaris Therapeutics Inc
      05/02/20237:01AMGlobeNewswire Inc.Aclaris Therapeutics to Announce First Quarter 2023 Financial Results on May 8, 2023NASDAQ:ACRSAclaris Therapeutics Inc
      04/20/20237:04AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACRSAclaris Therapeutics Inc
      04/20/20237:02AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ACRSAclaris Therapeutics Inc
      04/20/20237:01AMEdgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ACRSAclaris Therapeutics Inc
      04/14/20237:12AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      04/10/20234:32PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ACRSAclaris Therapeutics Inc
      03/31/20234:21PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      03/27/20234:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      03/27/20237:00AMGlobeNewswire Inc.Aclaris Therapeutics to Participate in the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual ConferenceNASDAQ:ACRSAclaris Therapeutics Inc
      03/17/20235:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      03/16/20234:49PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACRSAclaris Therapeutics Inc
      03/09/20235:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      03/06/20237:00AMGlobeNewswire Inc.Aclaris Therapeutics Announces Preliminary Topline Data from 12-Week Phase 2a Study of Oral Zunsemetinib (ATI-450) for Moderate to Severe Hidradenitis SuppurativaNASDAQ:ACRSAclaris Therapeutics Inc
      02/23/20234:05PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      02/23/20234:04PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ACRSAclaris Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ACRS